50242-143-01 |
50242-143 |
HUMAN PRESCRIPTION DRUG |
Actemra ACTPen |
tocilizumab |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20181119 |
N/A |
BLA |
BLA125472 |
Genentech, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
1 SYRINGE, GLASS in 1 BOX (50242-143-01) / .9 mL in 1 SYRINGE, GLASS |
50242-143-86 |
50242-143 |
HUMAN PRESCRIPTION DRUG |
Actemra ACTPen |
tocilizumab |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20181119 |
N/A |
BLA |
BLA125472 |
Genentech, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
1 SYRINGE, GLASS in 1 BOX (50242-143-86) / .9 mL in 1 SYRINGE, GLASS |
50242-138-01 |
50242-138 |
HUMAN PRESCRIPTION DRUG |
Actemra |
tocilizumab |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20131021 |
N/A |
BLA |
BLA125472 |
Genentech, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
1 SYRINGE, GLASS in 1 BOX (50242-138-01) / .9 mL in 1 SYRINGE, GLASS |
50242-138-86 |
50242-138 |
HUMAN PRESCRIPTION DRUG |
Actemra |
tocilizumab |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20131021 |
N/A |
BLA |
BLA125472 |
Genentech, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
1 SYRINGE, GLASS in 1 BOX (50242-138-86) / .9 mL in 1 SYRINGE, GLASS |